Neuropace Stock Price on December 18, 2024

NPCE Stock  USD 11.14  0.30  2.62%   
If you're considering investing in Neuropace Stock, it is important to understand the factors that can impact its price. As of today, the current price of Neuropace stands at 11.14, as last reported on the 25th of December, with the highest price reaching 11.44 and the lowest price hitting 11.10 during the day. Neuropace appears to be slightly risky, given 3 months investment horizon. Neuropace has Sharpe Ratio of 0.17, which conveys that the firm had a 0.17% return per unit of risk over the last 3 months. By analyzing Neuropace's technical indicators, you can evaluate if the expected return of 0.94% is justified by implied risk. Please exercise Neuropace's Mean Deviation of 3.68, downside deviation of 3.64, and Risk Adjusted Performance of 0.126 to check out if our risk estimates are consistent with your expectations.
  
At present, Neuropace's Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. . At present, Neuropace's Price Earnings To Growth Ratio is projected to slightly decrease based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 13.55, whereas Price Earnings Ratio is forecasted to decline to (8.49). Neuropace Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.1727

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsNPCE
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 5.45
  actual daily
48
52% of assets are more volatile

Expected Return

 0.94
  actual daily
18
82% of assets have higher returns

Risk-Adjusted Return

 0.17
  actual daily
13
87% of assets perform better
Based on monthly moving average Neuropace is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Neuropace by adding it to a well-diversified portfolio.
Price Book
35.035
Enterprise Value Ebitda
(16.94)
Price Sales
4.5015
Shares Float
11.2 M
Wall Street Target Price
16.1667

Neuropace Main Headline on 18th of December 2024

MOUNTAIN VIEW, Calif., Dec. 18, 2024 -- NeuroPace, Inc. , a medical device company focused on transforming the lives of people living

Neuropace Valuation on December 18, 2024

It is possible to determine the worth of Neuropace on a given historical date. On December 18, 2024 Neuropace was worth 11.69 at the beginning of the trading date compared to the closed value of 10.64. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Neuropace stock. Still, in general, we apply an absolute valuation method to find Neuropace's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Neuropace where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Neuropace's related companies.
 Open High Low Close Volume
  11.59    12.41    11.30    11.52    103,674  
12/18/2024
  11.69    12.23    9.92    10.64    86,205  
  11.01    11.66    10.76    11.14    55,515  
Backtest Neuropace  |  Neuropace History  |  Neuropace Valuation PreviousNext  
Open Value
11.69
10.64
Closing Value
28.05
Upside

Neuropace Trading Date Momentum on December 18, 2024

On December 19 2024 Neuropace was traded for  11.14  at the closing time. The top price for the day was 11.66  and the lowest listed price was  10.76 . The trading volume for the day was 55.5 K. The trading history from December 19, 2024 was a factor to the next trading day price growth. The trading delta at closing time against the next closing price was 4.70% . The trading delta at closing time against the current closing price is 6.67% .
JavaScript chart by amCharts 3.21.1512/18/2024Dec 09Dec 11Dec 13Dec 15Dec 17Dec 19Dec 21Dec 2310.811.011.211.4

Neuropace Fundamentals Correlations and Trends

By evaluating Neuropace's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Neuropace's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Neuropace financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Neuropace Stock history

Neuropace investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Neuropace is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Neuropace will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Neuropace stock prices may prove useful in developing a viable investing in Neuropace
Last ReportedProjected for Next Year
Common Stock Shares Outstanding25.9 M27 M
Net Loss-42.4 M-44.5 M

Neuropace Quarterly Net Working Capital

67.64 Million

100%

Neuropace Stock Technical Analysis

Neuropace technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Neuropace technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Neuropace trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Neuropace Period Price Range

Low
December 25, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Neuropace cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Neuropace December 25, 2024 Market Strength

Market strength indicators help investors to evaluate how Neuropace stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Neuropace shares will generate the highest return on investment. By undertsting and applying Neuropace stock market strength indicators, traders can identify Neuropace entry and exit signals to maximize returns

Neuropace Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Neuropace's price direction in advance. Along with the technical and fundamental analysis of Neuropace Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Neuropace to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Neuropace Stock analysis

When running Neuropace's price analysis, check to measure Neuropace's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neuropace is operating at the current time. Most of Neuropace's value examination focuses on studying past and present price action to predict the probability of Neuropace's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neuropace's price. Additionally, you may evaluate how the addition of Neuropace to your portfolios can decrease your overall portfolio volatility.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device